Skip to main content

Altomari Alfred

No open-market purchases or sales filed in the past year.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
–
0 filings
Net
–
Bought minus sold
Companies
0
With open-market trades

Trades

Every Form 4 that lists Altomari Alfred as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

AGRX Agile Therapeutics Inc

Chief Executive Officer4 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Aug 29, 2022 (view filing)8:30 AM ETAug 263 daysAltomari AlfredChief Executive OfficerPPurchase+50.0K$0.45+$22.5K+348.6%64.3K after
Oct 14, 2021 (view filing)Oct 131 dayAltomari AlfredChief Executive OfficerPPurchase+58.8K––+11.4%573.7K after
Oct 14, 2021 (view filing)Oct 131 dayAltomari AlfredChief Executive OfficerPPurchase+29.4K–––29.4K afterDerivative
Jul 29, 2021 (view filing)Jul 29Same dayAltomari AlfredChief Executive OfficerPPurchase+26.2K$1.26+$33.0K+5.4%514.9K after